MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-20 |
Device Problems
Mechanical Problem (1384); Failure to Disconnect (2541)
|
Patient Problems
Scar Tissue (2060); Therapeutic Effects, Unexpected (2099); No Known Impact Or Consequence To Patient (2692)
|
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8780, serial#: (b)(4), implanted: (b)(6) 2015, explanted: (b)(6) 2020, product type: catheter.Other relevant device(s) are: product id: 8780, serial/lot#: (b)(4), ubd: 25-mar-2017, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider via a company representative regarding a patient receiving gablofen 2000mcg/ml at 600 mcg/day with 50 mcg bolus on flex via an implantable pump.On (b)(6) 2020 it was reported that the patient had a pump replacement due to approaching eri (elective replacement indicator).There were no known issues with the pump.There were intermittent increases over a few months which led the clinicians to believe something potentially going on with the catheter.There were no diagnostics or troubleshooting performed.Since the patient was less than a year from eri they decided to go ahead and replace the pump and investigate the catheter during the pump exchange.During the procedure it was discovered that the pump connector appeared to have scar tissue built up around it and the surgeon found it difficult to disconnect the connector from the old pump.They were finally able to remove the pump connector.To be sure all parts of system was working correctly the surgeon made the decision to give the patient an entirely new catheter with the replacement of the pump.The issue was resolved at the time of the report and it was noted that the healthcare provider would not have any further information regarding the event.The patient status was noted as alive, no injury and no further complications were reported or anticipated regarding the event.
|
|
Manufacturer Narrative
|
H3 ¿ analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received, and it was reported that the exact date for when the intermittent increases began was unknown, but per the hcp (healthcare professional), it had been ¿over the last 6 months give or take¿.No further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
H6: analysis of the pump revealed pump motor gear train anomaly corrosion and or wear and or lubrication; stall due to shaft-bearing.Analysis of the catheter revealed no significant anomaly, sc connector damaged at explant.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|